Clinical Trial Update: Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for NMS-03597812 in adults with relapsed/refractory acute myeloid leukemia; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• NMS-03597812

Snippet

Sponsor: Nerviano Medical Sciences | Conditions: Relapsed/Refractory Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING